These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7389234)
21. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)]. Miguet JP; Allemand H; Joanne C; Dhumeaux D Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958 [No Abstract] [Full Text] [Related]
22. Antipyrine estimations in the rabbit using gas--liquid chromatography: a reliable method for studying factors affecting oxidative drug metabolism. Chambers DM; Jefferson GC J Pharmacol Methods; 1981 Jan; 5(1):59-66. PubMed ID: 7265986 [TBL] [Abstract][Full Text] [Related]
23. Enhanced drug metabolism and renal dysfunction. Németh I; Szeleczki T Br J Clin Pharmacol; 1981 Jan; 11(1):92-3. PubMed ID: 7213515 [No Abstract] [Full Text] [Related]
24. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation. Scavone JM; Greenblatt DJ; LeDuc BW; Blyden GT; Luna BG; Harmatz JS Pharmacology; 1990; 40(2):77-84. PubMed ID: 2345775 [TBL] [Abstract][Full Text] [Related]
25. Impairment of drug metabolism in polycystic non-parasitic liver disease. Sotaniemi EA; Luoma PV; Järvensivu PM; Sotaniemi KA Br J Clin Pharmacol; 1979 Oct; 8(4):331-5. PubMed ID: 508507 [TBL] [Abstract][Full Text] [Related]
26. How potent is the inhibition of drug metabolism by omeprazole? Webster LK; Jones DB; Smallwood RA Lancet; 1984 Sep; 2(8405):761. PubMed ID: 6148515 [No Abstract] [Full Text] [Related]
27. The interaction of cigarette smoking and chronic drug ingestion on human drug metabolism. Cooksley WG; Farrell GC; Cash GA; Powell LW Clin Exp Pharmacol Physiol; 1979; 6(5):527-33. PubMed ID: 498592 [TBL] [Abstract][Full Text] [Related]
28. Assessment of the drug metabolism capacity of the liver. Park BK Br J Clin Pharmacol; 1982 Nov; 14(5):631-51. PubMed ID: 6128018 [No Abstract] [Full Text] [Related]
33. Ascorbic acid and drug metabolism in cynomologus monkeys. Green M; Turnbull J; Sauberlich H; Omaye S Proc West Pharmacol Soc; 1978; 21():341-4. PubMed ID: 99749 [No Abstract] [Full Text] [Related]
34. Interindividual variations in drug disposition. Clinical implications and methods of investigation. Breimer DD Clin Pharmacokinet; 1983; 8(5):371-7. PubMed ID: 6627809 [No Abstract] [Full Text] [Related]
35. Editorial: Drug metabolism in disease. Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718 [No Abstract] [Full Text] [Related]
36. Lead and polychlorinated biphenyls: effects on heme and drug metabolism. Alvares AP; Kappas A Drug Metab Rev; 1979; 10(1):91-106. PubMed ID: 118861 [No Abstract] [Full Text] [Related]
37. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery. Chauhan CK; Nanivadekar SA; Billimoria FR Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749 [TBL] [Abstract][Full Text] [Related]
38. Drug metabolism and disposition at varying levels of protein and calories in human subjects. Nutr Rev; 1985 Mar; 43(3):71-2. PubMed ID: 3887240 [No Abstract] [Full Text] [Related]
39. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408 [No Abstract] [Full Text] [Related]
40. Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine. Sultatos LG; Dvorchik BH; Vesell ES; Shand DG; Branch RA Clin Pharmacokinet; 1980; 5(3):263-73. PubMed ID: 7389235 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]